Business
TICE BCG (Merck) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Key market opportunities include expanding bladder cancer screening programs, optimizing dosing regimens, increasing uro-oncology research investments, and growing demand for non-surgical treatments. Personalized medicine and higher healthcare spending also fuel growth, while tariffs prompt local production initiatives.Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "TICE BCG Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com
About this update from Merck & Company, Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Key market opportunities include expanding bladder cancer screening programs, optimizing dosing regimens, increasing uro-oncology research investments, and growing demand for non-surgical treatments. Personalized medicine and higher healthcare spending also fuel growth, while tariffs prompt local production initiatives.","length":321,"tagName":"p"},{"type":"text","content":"Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "TICE BCG Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.","length":210,"tagName":"p"},{"type":"text","content":"The TICE BCG market report offers comprehensive insights into market statistics, including global market size, regional shares, trends, and industry opportunities. It provides an extensive analysis of the current and future state of the industry.","length":246,"tagName":"p"},{"type":"text","content":"The historic growth of the TICE BCG market can be attributed to its well-established clinical efficacy and widespread adoption in urology practices. This growth is supported by recommendations in bladder cancer treatment guidelines, robust hospital-based administration infrastructure, and in-depth clinical experience with immunotherapy.","length":338,"tagName":"p"},{"type":"text","content":"The projected growth will likely be driven by the expansion of bladder cancer screening programs, optimized dosing regimens, increased investments in uro-oncology research, and a higher demand for non-surgical cancer treatments. Trends include the continuous use of immunotherapy in NMIBC management, a rising focus on recurrence prevention, and the standardization of intravesical therapies along with expanded high-risk bladder cancer treatment protocols and enhanced post-treatment clinical surveillance.","length":...